ShanHib Liquid is a vaccine against infections caused by Hemophilus influenzae type-B. Vaccination with ShanHib liquid protects infants from childhood infections caused due to Hemophilus influenzae type-B. It is used for vaccination of infants more than 6 weeks of age and given as 3 doses with a  booster at 15-18 months.

ShanHib (Lyophilised) is a vaccine against infections caused by Hemophilus influenzae type-B. ShanHib is presented as Lyophilised powder to be reconstituted with the Diluent or DTP-Hep-B tetravalent vaccine prior to administration. Vaccination with ShanHib protects infants from childhood infections caused due to Hemophilus influenzae type-B. It is used for vaccination of infants more than 6 weeks of age and given as 3 doses with a  booster at 15-18 months.